Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.

Why Flexion Therapeutics Shares Shot 12.8% Higher in July

TheMotleyFool

0 0

Why Flexion Therapeutics Shares Shot 12.8% Higher in July

After the company hosted an investor's day on July 10, shares in Flexion Therapeutics (NASDAQ: FLXN) jumped 12.8% last month, according to S&P Global Market Intelligence.

Flexion Therapeutics doesn't have any medications on the market yet, but that could change later this year when the U.S. Food and Drug Administration issues a go/no-go decision on Zilretta, the company's treatment for chronic knee pain caused by osteoarthritis.

IMAGE SOURCE: GETTY IMAGES.

Source: Fool.com